a Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), University of Colorado Denver , Aurora , CO , USA.
Hum Vaccin Immunother. 2019;15(7-8):1592-1598. doi: 10.1080/21645515.2018.1547607. Epub 2019 Jan 16.
There is a critical need for campaigns and interventions to increase rates of human papillomavirus (HPV) vaccination among U.S. adolescents. Healthcare providers are key stakeholders in parents' HPV vaccine decision-making. The current study presents the evaluation of secondary outcomes in a multi-component communication-based intervention to improve healthcare providers' communication about HPV vaccination. Evaluation was conducted via surveys of providers participating in a 12-month randomized controlled trial. Findings suggest use of communication components (combined use of the presumptive approach [PA] with all patients, and motivational interviewing and a fact sheet with vaccine hesitant parents) contributed to providers in the intervention group reporting higher perceived levels of parental HPV vaccine acceptance than control providers, as well as increased vaccination rates in the intervention arm in the main RCT.
美国青少年人乳头瘤病毒(HPV)疫苗接种率亟待提高,为此有必要开展相关活动和干预。医疗保健提供者是父母 HPV 疫苗决策的关键利益相关者。本研究介绍了基于沟通的多组分干预措施中次要结局的评估结果,该措施旨在改善医疗保健提供者 HPV 疫苗接种沟通。评估是通过参与为期 12 个月的随机对照试验的提供者调查进行的。研究结果表明,沟通组件的使用(对所有患者联合使用假定方法[PA],对有抵触情绪的父母使用动机性访谈和疫苗接种情况说明书)有助于干预组的提供者报告称,与对照组提供者相比,他们认为父母 HPV 疫苗接种接受度更高,且主要 RCT 中的干预组疫苗接种率也有所提高。